Belarus

Krka has been officially represented in Belarus since 1996. Before that, state distribution companies marketed Krka products.  

At the very beginning we launched the ACE inhibitor enalapril. Since then, we have launched numerous new medicines such as losartan, pantoprazole, valsartan, telmisartan, all from the perindopril family. With the perindopril/amlodipine/indapamide combination, we offered the first triple product to the market, even before the originator; now, it is part of the TOP 10 medicines in the market. We aim to focus on the priority products according to the market needs. Therefore, Krka products rank first among the medicines for the renin-angiotensin system, proton pump inhibitors and sore throat remedies. With Krka products, we offer new treatment options for Belarusian patients in accordance with the latest guidelines. As a result, the professional health care public perceives Krka as an innovative generic pharmaceutical company.

Today Krka is a leading generic producer in the Belarus market. It offers prescription pharmaceuticals and non-prescription products for human use as well as animal health products.